Cyprus vs Iceland: Reported rate of new cervical cancer cases
Cyprus
6.86 per 100,000 women
in 2017
Iceland
6.24 per 100,000 women
in 2022
Cyprus rank
28th
Iceland rank
30th
Reported rate of new cervical cancer cases over time
- Cyprus
- Iceland
How they compare
Cyprus currently reports 6.86 per 100,000 women against 6.24 per 100,000 women in Iceland, a difference of 0.62 per 100,000 women.
That makes Cyprus's figure about 1.1 times Iceland's.
Across all 20 years both countries report, Iceland has been ahead every year.
Cyprus ranks 28th and Iceland ranks 30th of 46 countries.
Iceland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cyprus | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 5.99 per 100,000 women | 8.57 per 100,000 women | 2.58 per 100,000 women | Iceland |
| 2000s | 4.44 per 100,000 women | 8.54 per 100,000 women | 4.1 per 100,000 women | Iceland |
| 2010s | 5.85 per 100,000 women | 8.92 per 100,000 women | 3.07 per 100,000 women | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Cyprus or Iceland?
- Cyprus, at 6.86 per 100,000 women against 6.24 per 100,000 women in Iceland as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Cyprus and Iceland?
- 0.62 per 100,000 women, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Iceland?
- 20 years are reported by both, from 1998 to 2017.
- How do Cyprus and Iceland rank globally for reported rate of new cervical cancer cases?
- Cyprus ranks 28th and Iceland ranks 30th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.